Rational antibody-based HIV-1 vaccine design: current approaches and future directions
- 30 June 2010
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 22 (3), 358-366
- https://doi.org/10.1016/j.coi.2010.02.012
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Role of lipid structure in the humoral immune response in mice to covalent lipid–peptides from the membrane proximal region of HIV-1 gp41Vaccine, 2009
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysNature Medicine, 2009
- Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challengeVirology, 2008
- Molecular architecture of native HIV-1 gp120 trimersNature, 2008
- Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particlesVirology, 2008
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteersVaccine, 2008
- A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120Virology, 2007
- Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion stateVaccine, 2007
- Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteinsVirology, 2007
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007